Metastatic thyroid cancer occurring as an unknown primary lesion: The role of F-18 FDG positron emission tomography

Clinical Nuclear Medicine

Volumn 26, Issue 5, 2001, Pages 396-399

  Dede, Faut ^a   Yulisa Ajoedi, Nyimas Diana ^a   Ansari, Selim M ^a   Jana, Suman ^a   Heiba, Sherif I ^a   Abdel Dayem, Hussein M ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ST VINCENT S HOSPITAL   (United States)

Author keywords

F 18 Fluorodeoxyglucose Positron Emission Tomography; Metastatic Thyroid Cancer; Unknown Primary

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CARE COST; HUMAN; HUMAN TISSUE; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; THYROID CANCER; THYROID GLAND; TUMOR LOCALIZATION;

AGED; BONE NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 0035034347     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200105000-00004     Document Type: Article

References (9)

1. Clinical experience with dual head gamma camera coincidence imaging
2. Detection of unknown occult primary tumors using positron emission tomography
3. Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors
4. Oncologic application of positron emission tomography with fluorine-18 fluorodeoxyglucose
5. PET and 18F in oncology: A clinical update
6. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)
7. PET/(18-F)FDG and I-131 in patients with thyroid carcinoma
8. Improved detection of locally recurrent and metastatic thyroid cancer patients with persistent elevated thyroglobulin using FDG PET scanning
9. Uptake of 18F-fluoro-2-deoxy-D-glucose by thyroid cancer: Implication for diagnosis and therapy